BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1691798)

  • 21. Local expression of acute phase serum amyloid A mRNA in rheumatoid arthritis synovial tissue and cells.
    Kumon Y; Suehiro T; Hashimoto K; Nakatani K; Sipe JD
    J Rheumatol; 1999 Apr; 26(4):785-90. PubMed ID: 10229397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Day to day changes in SAA (serum amyloid A) values of healthy subjects and the effect of dexamethasone administration].
    Yamada T; Sakurai A
    Rinsho Byori; 1997 Jul; 45(7):696-8. PubMed ID: 9256019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synovial fluid from rheumatoid arthritis patients contains sufficient levels of IL-1 beta and IL-6 to promote production of serum amyloid A by Hep3B cells.
    McNiff PA; Stewart C; Sullivan J; Showell HJ; Gabel CA
    Cytokine; 1995 Feb; 7(2):209-19. PubMed ID: 7780041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyloidosis is frequently undetected in patients with rheumatoid arthritis.
    Koivuniemi R; Paimela L; Suomalainen R; Tornroth T; Leirisalo-Repo M
    Amyloid; 2008 Dec; 15(4):262-8. PubMed ID: 19065298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cystatin C binds serum amyloid A, downregulating its cytokine-generating properties.
    Bokarewa M; Abrahamson M; Levshin N; Egesten A; Grubb A; Dahlberg L; Tarkowski A
    J Rheumatol; 2007 Jun; 34(6):1293-301. PubMed ID: 17552057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two distinct clinical courses of renal involvement in rheumatoid patients with AA amyloidosis.
    Uda H; Yokota A; Kobayashi K; Miyake T; Fushimi H; Maeda A; Saiki O
    J Rheumatol; 2006 Aug; 33(8):1482-7. PubMed ID: 16881107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloid precursors and amyloidosis in inflammatory arthritis.
    Cunnane G
    Curr Opin Rheumatol; 2001 Jan; 13(1):67-73. PubMed ID: 11148718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzyme-linked immunosorbent assay of serum protein SAA in rhesus monkeys with secondary amyloidosis.
    Doepel FM; Glorioso JC; Newcomer CE; Skinner M; Abrams GD
    Lab Invest; 1981 Jul; 45(1):7-13. PubMed ID: 7253566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brefeldin A inhibits experimentally induced AA amyloidosis.
    Stenstad T; Husby G
    J Rheumatol; 1996 Jan; 23(1):93-100. PubMed ID: 8838515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction.
    Bijl M; Bootsma H; Van Der Geld Y; Limburg PC; Kallenberg CG; Van Rijswijk MH
    Ann Rheum Dis; 2004 Jul; 63(7):831-5. PubMed ID: 15194579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A study of amyloidogenesis in relation to SAA levels in inflammatory diseases].
    Tomita M; Isobe T; Matsumoto J; Fujita T
    Ryumachi; 1985 Apr; 25(2):110-4. PubMed ID: 4035466
    [No Abstract]   [Full Text] [Related]  

  • 32. [Serum amyloid A (SAA)--pathogenicity and implication of appearance in plasma].
    Yamada T
    Rinsho Byori; 2006 May; 54(5):509-12. PubMed ID: 16789422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Syrian and Armenian hamsters differ in serum amyloid A gene expression. Identification of novel Syrian hamster serum amyloid A subtypes.
    de Beer MC; de Beer FC; Beach CM; Gonnerman WA; Carreras I; Sipe JD
    J Immunol; 1993 Jun; 150(12):5361-70. PubMed ID: 8515064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Quantitation and clinical significance of human serum amyloid A protein].
    Yamada T; Uchiyama K; Yakata M; Nakano M; Gejyo F; Arakawa M
    Rinsho Byori; 1988 Apr; 36(4):459-63. PubMed ID: 3136263
    [No Abstract]   [Full Text] [Related]  

  • 35. Heterogeneity of human amyloid protein AA and its related serum protein, SAA.
    Skogen B; Sletten K; Lea T; Natvig JB
    Scand J Immunol; 1983 Jan; 17(1):83-8. PubMed ID: 6552032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Inflammatory markers; C-reactive protein (CRP) and serum amyloid A (SAA)].
    Yamada T
    Rinsho Byori; 2005 Jun; 53(6):558-61. PubMed ID: 16026085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amyloid A amyloidosis secondary to rheumatoid arthritis: pathophysiology and treatments.
    Nakamura T
    Clin Exp Rheumatol; 2011; 29(5):850-7. PubMed ID: 22011672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical significance of amyloid protein analysis in biochemical tests].
    Yamada T; Yakata M
    Nihon Rinsho; 1989 Dec; 48 Suppl():89-91. PubMed ID: 2622024
    [No Abstract]   [Full Text] [Related]  

  • 39. Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis.
    De Beer FC; Mallya RK; Fagan EA; Lanham JG; Hughes GR; Pepys MB
    Lancet; 1982 Jul; 2(8292):231-4. PubMed ID: 6124669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum amyloid A protein (SAA) subtypes in acute and chronic inflammatory conditions.
    Maury CP; Ehnholm C; Lukka M
    Ann Rheum Dis; 1985 Oct; 44(10):711-5. PubMed ID: 3931569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.